Private Equity, VC & Investor
Breega vs Cherry Ventures
Structured technology and market comparison · 2026
Direct Feature Comparison
Breega · vs · Cherry VenturesEuropean and African early-stage venture capital fund manager.
European early-stage venture capital firm backing technology startups.
Analyze all overlapping signals and tech stacks for Breega and Cherry Ventures
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between Breega and Cherry Ventures?
When comparing Breega and Cherry Ventures, both platforms operate within the Private Equity, VC & Investor ecosystem. Breega is positioned as European and African early-stage venture capital fund manager, whereas Cherry Ventures focuses on European early-stage venture capital firm backing technology startups. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to Breega and Cherry Ventures?
When evaluating Breega and Cherry Ventures, enterprise buyers also consider other platforms in Private Equity, VC & Investor. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of Breega and Cherry Ventures compare?
Breega is headquartered in FR (founded in 2013) with 10–49 employees. Cherry Ventures is based in DE (founded in 2012) with 10–49 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: Breega vs Cherry Ventures
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
Breega
Recent Signals
- ·EU-Startups (European Venture)Funding
Cori Clinical Raises €3.8M to Accelerate Clinical Trials
London-based Cori Clinical, a startup providing an AI-powered intelligence layer for clinical trials, has raised €3.8 million in a Seed round led by Breega, with participation from Enzo, Heartfelt, Together Ventures, and Bynd. The company plans to use the funds to expand delivery capacity, grow its team, and deepen regulatory and clinical intelligence in its platform. Dr. Emma Ogburn joins as Chief Clinical Officer from Lindus Health. Founded in 2025 by Jorn Jansen Schoonhoven (CEO) and Patricio Fernández (CTO), Cori Clinical creates a 'living blueprint' for trials, integrating internal knowledge with external data from registries and regulatory bodies like FDA, MHRA, and EMA. The startup claims its approach could reduce average trial set-up costs by at least 33%. It already works with two of the top five global CROs and has customers like Erasmus MC.
- Cori Clinical raised €3.8 million in a Seed round led by Breega.
- Participants include Enzo, Heartfelt, Together Ventures, and Bynd.
- Dr. Emma Ogburn joins as Chief Clinical Officer from Lindus Health.
Cherry Ventures
Recent Signals
- ·Trending Topics (DACH/CEE Innovation & Tech)Startup Research
Cherry Ventures Report: European Startups Mostly Solo Founders
Cherry Ventures' 'Heartbeat' report, based on 10,000 European startups in their first 18 months, reveals key trends: 75% are solo founders, women found only 10.1% of startups, and master's degrees are more common than MBAs. Co-founders are typically met at work, not university. Only 7% went through accelerators. Amsterdam and Zurich lead in per-capita startup creation. AI-first software has overtaken classic SaaS as the largest category. Munich is Europe's hardware hub. The report also highlights a brain drain pattern where many SF founders studied in Europe, and founders with US degrees raise double the capital.
- Cherry Ventures analyzed 10,000 European startups in their first 18 months.
- 75% of startups are founded by a single person.
- Female founders account for only 10.1% of startups.
- ·Trending Topics (DACH/CEE Innovation & Tech)Industry Research
75% of European Founders Start Solo: Cherry Ventures Report
A new report by Berlin-based VC fund Cherry Ventures, titled 'Heartbeat', analyzes 10,000 European startups in their first 18 months, spanning 10,000 founders across 89 cities and over €5 billion in capital raised. Key findings reveal that 75% of startups are solo-founded, with only 10.1% of founders being female. Master's degrees are 4.3 times more common than MBAs, and co-founders are typically met at work. Only 7% attended accelerators, with Y Combinator most common. Amsterdam and Zurich lead per capita, while London leads in absolute numbers. AI-first software has overtaken classic SaaS as the largest category (22.5% vs 20.9%). Munich is Europe's hardware capital. The report highlights a brain drain: 72% of San Francisco founders were educated in Europe, and U.S. degrees correlate with double initial funding.
- 75% of European startups are solo-founded; only 10.1% of founders are women.
- Master's degrees are 4.3 times more common than MBAs; in deep tech, doctorates outnumber MBAs nearly 10 to 1.
- AI-first software is now the largest startup category at 22.5%, surpassing classic SaaS at 20.9%.
- ·Gründerszene (DACH Startups & Scaleups)Startup Funding
Antler Study: Key Factors for German Startups' Series A Success
A new analysis by venture capital firm Antler reveals that only 24% of German startups successfully transition from Seed to Series A funding. The study, which examined 27,602 funding rounds from over 3,000 startups between 2015 and 2026, identifies five key factors that significantly increase the likelihood of reaching a Series A round: raising at least €2 million in the Seed round, having an institutional VC as lead investor, having at least three investors in the Seed round, having a Pre-Seed investor participate in the Seed round, and completing the Seed round within twelve months of the Pre-Seed. Startups meeting all five criteria achieve Series A in 51.1% of cases. The analysis also highlights the growing gap between new startup creations and follow-on financing, with 3,568 startups founded in 2025 but only 71 reaching Series A. Despite this, Germany's conversion rate of 18.9% for the 2022 cohort remains strong compared to other European markets.
- Only 24% of German startups successfully transition from Seed to Series A funding.
- Antler analyzed 27,602 funding rounds from over 3,000 startups between 2015 and 2026.
- Startups meeting all five key criteria reach Series A in 51.1% of cases.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners Breega and Cherry Ventures share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks